Marla H. Daves

Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.

Evanette K. Burrows, Edward M. Krause, Mark J. Ramos, 2022, The Lancet. Haematology.

Accuracy of Adverse Event Ascertainment in Clinical Trials for Pediatric Acute Myeloid Leukemia.

A. Troxel, A. Seif, T. Alonzo, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A report from the Leukemia Electronic Abstraction of Records Network on risk of hepatotoxicity during pediatric acute lymphoblastic leukemia treatment

Evanette K. Burrows, M. Scheurer, P. Lupo, 2022, Haematologica.

Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.

Cheng Cheng, Aristotelis Tsirigos, Iannis Aifantis, 2020, Cancer cell.

A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children’s Oncology Group

A. Seif, T. Alonzo, R. Gerbing, 2016, Leukemia & lymphoma.

Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

A. Seif, T. Alonzo, R. Gerbing, 2017, Haematologica.

Using Improvement Science to Promote Evidence-Based Practice in a Childhood Cancer and Hematology Center

M. Hockenberry, M. Bernhardt, K. Kamdar, 2012, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma

R. Nickel, F. Keller, T. Cooper, 2014, Pediatric blood & cancer.

Treatment of an adolescent with chronic myeloid leukemia and the T315I mutation with ponatinib

R. Nickel, F. Keller, Marla H. Daves, 2015, Pediatric blood & cancer.

A case series of pediatric oncology patients undergoing successful rapid etoposide desensitization

N. Rider, S. Anvari, J. Foster, 2019, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Longer Time to the Start of Continuation Therapy Is Associated with Improved Survival In High Risk Pediatric Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG)

S. Hunger, M. Devidas, W. Bowman, 2010 .

Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma

R. Nickel, F. Keller, T. Cooper, 2014, Pediatric blood & cancer.